MedTrace Logo

15-Hydroxyprostaglandin Dehydrogenase in Osteoarthritis and Ankylosing Spondylitis

NCT07751263 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 51

Last updated 2026-08-07

No results posted yet for this study

Summary

To evaluate serum and synovial fluid 15-PGDH levels in patients with osteoarthritis and ankylosing spondylitis and determine their associations with clinical and musculoskeletal ultrasound features.

To compare 15-PGDH concentrations among patients with knee osteoarthritis, and ankylosing spondylitis with knee effusion

To evaluate whether serum 15-PGDH reflects intra-articular 15-PGDH concentrations.

Analysis the level of 15-PGDH in relation to disease activity and severity of both diseases.

Conditions

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-08-02
Primary Completion
2027-08-02
Completion
2028-08-02

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07751263 on ClinicalTrials.gov